Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Assets (2016 - 2025)

Historic Assets for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $1.7 billion.

  • Amphastar Pharmaceuticals' Assets rose 783.37% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 783.37%. This contributed to the annual value of $1.6 billion for FY2024, which is 426.71% up from last year.
  • Amphastar Pharmaceuticals' Assets amounted to $1.7 billion in Q3 2025, which was up 783.37% from $1.6 billion recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Assets' 5-year high stood at $1.7 billion during Q3 2025, with a 5-year trough of $645.7 million in Q1 2021.
  • For the 5-year period, Amphastar Pharmaceuticals' Assets averaged around $1.1 billion, with its median value being $1.4 billion (2023).
  • In the last 5 years, Amphastar Pharmaceuticals' Assets soared by 11255.59% in 2023 and then rose by 3.53% in 2024.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Assets stood at $671.5 million in 2021, then rose by 10.49% to $742.0 million in 2022, then surged by 103.9% to $1.5 billion in 2023, then increased by 4.27% to $1.6 billion in 2024, then increased by 5.63% to $1.7 billion in 2025.
  • Its Assets stands at $1.7 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $1.6 billion for Q1 2025.